The appetite revolution has begun.
Are you thinking about how GLP1s could impact your brand and business?
The rollout of ‘miracle weight loss drugs’ could be the most disruptive event food and drink has ever experienced. Already taken by 8% of adults in the UK and 12% in the US, GLP-1s are growing fast, radically rewiring our relationship with food, appetite and indulgence.
The ramifications across CPG could be huge.
Following our recent GLP1 podcast, we put together a playbook to unpack the key shifts GLP1s are bringing to the food and drink industry – and what brand and innovation leaders can do to stay ahead.
A teaser of what's inside...
We set out thought starters to help prepare teams for how these drugs change consumers' relationship with food and drink and answer some of the big questions like:
- What do GLP1s actually do to the brand and body?
- How do users emotionally connect with food?
- What changes with flavour and the consumption experience?
- How do GLP1s affect socialising and mealtimes?
- What might it do to a user's sense of identity?
With input from Unilever, Carlsberg and Mintel leaders, it’s a good starting point for your GLP1 strategy.
Please enter your details to download the full report to your inbox.